Skye Bioscience Cash from Investing (TTM) Analysis

Skye Bioscience Inc (SKYE)

12.47 -0.09 (-0.72%) USD | NASDAQ | May 08, 14:32

Cash from Investing (TTM) Chart

Historical Cash from Investing (TTM) Data

View and export this data back to 2013. Upgrade now.

Date	Value
December 31, 2023	6.596M
September 30, 2023	12.27M
June 30, 2023	10.83M
March 31, 2023	10.75M
December 31, 2022	5.214M
September 30, 2022	-0.5061M
June 30, 2022	-0.1667M
March 31, 2022	-0.0822M
December 31, 2021	-0.0909M
September 30, 2021	-0.0441M
June 30, 2021	-0.0174M
March 31, 2021	-0.0179M
December 31, 2020	-0.0072M
September 30, 2020
June 30, 2020
March 31, 2020
December 31, 2019
September 30, 2019
June 30, 2019
March 31, 2019
December 31, 2018	-0.0044M

Date	Value
September 30, 2018	-0.024M
June 30, 2018	-0.024M
March 31, 2018	-0.0207M
December 31, 2017	-0.0197M
September 30, 2017	0.00
June 30, 2017	0.00
March 31, 2017	0.00
December 31, 2016	-0.0111M
September 30, 2016	-0.0111M
June 30, 2016	-0.0131M
March 31, 2016	-0.0131M
December 31, 2015	-0.002M
September 30, 2015
June 30, 2015
March 31, 2015
December 31, 2014
September 30, 2014
July 31, 2014	-0.0678M
April 30, 2014	0.011M
January 31, 2014	0.0094M
October 31, 2013	-0.0381M

Cash From Investing Definition

Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.

Read full definition.

Cash from Investing (TTM) Range, Past 5 Years

-0.5061M

Minimum

Sep 2022

12.27M

Maximum

Sep 2023

3.440M

Average

-0.0174M

Median

Jun 2021

Cash from Investing (TTM) Benchmarks